Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
42,093,400
-
Share change
-
-55,409,421
-
Total reported value
-
$103,979,091
-
Price per share
-
$2.47
-
Number of holders
-
30
-
Value change
-
-$189,358,191
-
Number of buys
-
10
-
Number of sells
-
105
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q4 2020
As of 31 Dec 2020,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,093,400 shares.
The largest 10 holders included
Silver Point Capital L.P., Park West Asset Management LLC, GABELLI & Co INVESTMENT ADVISERS, INC., JBF Capital, Inc., GABELLI FUNDS LLC, Context Capital Management, LLC, WINTON GROUP Ltd, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Russell Investments Group, Ltd., and HANCOCK WHITNEY CORP.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.